Ping Y. Huang PhD

Ping is Head of Drug Substance biologic processes for Oncology Early Development in Abbvie. He obtained Ph.D in Biochemical Engineering from University of Maryland Baltimore County in 1992. After post Doc in NC State, he joined Protein Design Lab which was later acquired by Abbvie. In the last 23 years, he led teams of scientists and engineers in bioprocess dev, tech transfer and scale-up. He worked on projects in least 30 INDs, two of them successfully progressed to BLA and FDA approvals in 2015 and 2016.